Muscular Dystrophy

Successful Regeneration of Human Skeletal Muscle in Mice Enables Accelerated Research in Muscular Dystrophy

January 27, 2014
Kennedy Krieger researchers develop valid and accurate model for FSHD

Baltimore, Md.Researchers at the Kennedy Krieger Institute recently announced study findings showing the successful development of a humanized preclinical model for facioscapulohumeral muscular dystrophy (FSHD), providing scientists with a much needed tool to accelerate novel therapeutic research and development.

NIH Funds New Muscular Dystrophy Research At Kennedy Krieger; Part Of Large Initiative To Fund Collaborations With Industry

June 18, 2013
Initiative to enable exploration of potential treatments in eight disease areas using existing compounds

Baltimore, Md. -- The National Institutes of Health has awarded a team from Kennedy Krieger Institute and the University of Washington with $2.9 million for the first year of an anticipated three-year grant to test a drug for Duchenne muscular dystrophy (DMD).  The award is part of a $12.7 million funding initiative to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer’s disease and schizophrenia.

Metabolic Myopathies

To find patient care programs and faculty treating metabolic myopathies at Kennedy Krieger Institute, please see the right-hand column below. Additional helpful information, including definitions, symptoms, Institute press releases, Potential magazine articles, and other resources outside the Institute, have also been provided for readers on this page.

Metabolic Myopathies Overview:

The metabolic myopathies comprise a diverse group of genetic disorders that cause impaired energy production in muscle. These disorders are organized into three major groups:

Congenital Myopathy

To find patient care programs and faculty treating congenital myopathy at Kennedy Krieger Institute, please see the right-hand column below. Additional helpful information, including definitions, symptoms, Institute press releases, Potential magazine articles, and other resources outside the Institute, have also been provided for readers on this page.

Millions Around World To Observe Rare Disease Day

January 14, 2011
World Rare Disease Day on February 28, 2011

(Baltimore, MD) Kennedy Krieger Institute will be joining the National Organization for Rare Disorders (NORD) and others around the world in observing World Rare Disease Day on February 28, 2011. On this day, millions of patients and their families will share their stories to focus a spotlight on rare diseases as an important global public health concern.

Muscular Dystrophy

To find patient care programs and faculty treating muscular dystrophy at Kennedy Krieger Institute, please see the right-hand column below. Additional helpful information, including definitions, symptoms, Institute press releases, Potential magazine articles, and other resources outside the Institute, have also been provided for readers on this page.

Syndicate content